Each capsule contains 100mg of Mazatec psilocybin mushrooms, which is 1/10th of a standard recreational dose of 1000mg. Therefore, one capsule is considered a "microdose".
Microdosing is the practice of taking very small, sub-perceptual doses of a psychoactive substance such as psilocybin or LSD. These small doses are intended to influence cognition subtly without causing noticeable alterations in perceptions and consciousness.
The Mazatec mushroom variety is moderately potent but typically provides a balanced experience without overwhelming effects, so it is a suitable choice for beginners and experienced microdosers alike. Comparatively, Golden Teacher is slightly milder in potency.
VioletDrift Harmony Microdose capsules were designed to support cognitive performance, creativity and emotional balance. The Mazatec mushroom variety was specifically chosen for this product because of their well known introspective and spiritual qualities which support mindfulness and emotional clarity during microdosing. Users may experience mood enhancement, improved emotional stability and light cognitive benefits. This product is ideal for those seeking a more meditative, grounded microdosing experience and since this variety is associated with Mazatec traditions, it may feel more meaningful for those interested in its spiritual history. If you prioritize spirituality, emotional balance and introspection, then this product is an ideal choice for you!
This product contains 100% organically grown Mazatec Psilocybe cubensis ground mushrooms cultivated in Canada,with no fillers or artificial additives. Each capsule is 100mg so you can accurately know and adjust your desired dose.
Each Microdose is encapsulated in a vegan capsule and securely put into a child-resistant bottle.
Take 1 capsule every 2-3 days or as part of a structured microdosing protocol such as, dosing for 4 consecutive days, then taking three days off. Avoid exceeding the recommended dosage to maintain the microdoses intended benefits.
Studies suggest that microdosing may help alleviate symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD). Emerging evidence shows a correlation between microdosing and improved mood, emotional regulation, and cognitive functioning, though the results are preliminary and require more rigorous trials. Research suggests that even at low doses, psychedelics may promote neuroplasticity (the brain's abilty to form new neural connections), potenitally improving mood and cognition without the disruptive effects of a full dose. While preliminary research and anecdotal evidence are promising, larger placebo-controlled trials are necessary to validate these findings and better understand the mechanisms behind microdosing effects.
